SCHEMBL5607534

SCHEMBL5607534

COC(=O)C(C)=Cc1ccc(OCc2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.62
GSK3B P49841 3/20 0.58
BACE1 P56817 3/20 0.58
MAOB P27338 2/20 0.56
NPC1 O15118 5/20 0.55
RAB9A P51151 5/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
KDM4E B2RXH2 4/20 0.54
MAPT P10636 3/20 0.54
GAA P10253 1/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
CASP3 P42574 1/20 0.53
SENP8 Q96LD8 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
SENP6 Q9GZR1 1/20 0.53
GPR55 Q9Y2T6 1/20 0.53
CYP1A2 P05177 1/20 0.52
CYP2C19 P33261 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7031464 0.87 NR1H4 (0.76) NR1H4GSK3BBACE1MAOBNPC1
SCHEMBL3662420 0.87 NR1H4 (0.63) NR1H4GSK3BBACE1MAOBNPC1
SCHEMBL3662418 0.87 NR1H4 (0.63) NR1H4GSK3BBACE1MAOBNPC1
SCHEMBL3994972 0.86 NR1H4 (0.79) NR1H4GSK3BBACE1MAOBNPC1
SCHEMBL3994975 0.86 NR1H4 (0.79) NR1H4GSK3BBACE1MAOBNPC1
SCHEMBL5607525 0.86 NR1H4 (0.62) NR1H4GSK3BBACE1MAOBNPC1
SCHEMBL5607528 0.86 NR1H4 (0.62) NR1H4GSK3BBACE1MAOBNPC1
SCHEMBL5606693 0.86 NR1H4 (0.61) NR1H4GSK3BBACE1MAOBNPC1
SCHEMBL5607888 0.86 NR1H4 (0.61) NR1H4GSK3BBACE1MAOBNPC1
SCHEMBL5607008 0.86 NR1H4 (0.61) NR1H4GSK3BBACE1MAOBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR NR1H4 220/4885GSK3B 2848/4885BACE1 1867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.